172 related articles for article (PubMed ID: 38504172)
21. Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.
Stevens LA; Barbieri JT; Piszczek G; Otuonye AN; Levine RL; Zheng G; Moss J
J Immunol; 2014 Dec; 193(12):6144-51. PubMed ID: 25392530
[TBL] [Abstract][Full Text] [Related]
22. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
[TBL] [Abstract][Full Text] [Related]
23. Differential involvement of gp130 signalling pathways in modulating tobacco carcinogen-induced lung tumourigenesis.
Miller A; Brooks GD; McLeod L; Ruwanpura S; Jenkins BJ
Oncogene; 2015 Mar; 34(12):1510-9. PubMed ID: 24727895
[TBL] [Abstract][Full Text] [Related]
24. Down-regulating IL-6/GP130 targets improved the anti-tumor effects of 5-fluorouracil in colon cancer.
Li S; Tian J; Zhang H; Zhou S; Wang X; Zhang L; Yang J; Zhang Z; Ji Z
Apoptosis; 2018 Jun; 23(5-6):356-374. PubMed ID: 29777330
[TBL] [Abstract][Full Text] [Related]
25. Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells.
Chen X; Tian J; Su GH; Lin J
Curr Cancer Drug Targets; 2019; 19(5):417-427. PubMed ID: 29714141
[TBL] [Abstract][Full Text] [Related]
26. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C
Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235
[TBL] [Abstract][Full Text] [Related]
27. Mono ADP-ribosylation inhibitors prevent inflammatory cytokine release in alveolar epithelial cells.
Del Vecchio M; Balducci E
Mol Cell Biochem; 2008 Mar; 310(1-2):77-83. PubMed ID: 18066713
[TBL] [Abstract][Full Text] [Related]
28. Sepsis induces interleukin 6, gp130/JAK2/STAT3, and muscle wasting.
Zanders L; Kny M; Hahn A; Schmidt S; Wundersitz S; Todiras M; Lahmann I; Bandyopadhyay A; Wollersheim T; Kaderali L; Luft FC; Birchmeier C; Weber-Carstens S; Fielitz J
J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):713-727. PubMed ID: 34821076
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6--a key regulator of colorectal cancer development.
Waldner MJ; Foersch S; Neurath MF
Int J Biol Sci; 2012; 8(9):1248-53. PubMed ID: 23136553
[TBL] [Abstract][Full Text] [Related]
30. Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
Xiao H; Bid HK; Chen X; Wu X; Wei J; Bian Y; Zhao C; Li H; Li C; Lin J
PLoS One; 2017; 12(7):e0180297. PubMed ID: 28672024
[TBL] [Abstract][Full Text] [Related]
31. Inactivation of platelet-derived growth factor-BB following modification by ADP-ribosyltransferase.
Saxty BA; Yadollahi-Farsani M; Upton PD; Johnstone SR; MacDermot J
Br J Pharmacol; 2001 Aug; 133(8):1219-26. PubMed ID: 11498506
[TBL] [Abstract][Full Text] [Related]
32. NAD-dependent ADP-ribosylation of the human antimicrobial and immune-modulatory peptide LL-37 by ADP-ribosyltransferase-1.
Picchianti M; Russo C; Castagnini M; Biagini M; Soldaini E; Balducci E
Innate Immun; 2015 Apr; 21(3):314-21. PubMed ID: 25128692
[TBL] [Abstract][Full Text] [Related]
33. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract][Full Text] [Related]
34. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
Tian J; Chen X; Fu S; Zhang R; Pan L; Cao Y; Wu X; Xiao H; Lin HJ; Lo HW; Zhang Y; Lin J
Breast Cancer Res Treat; 2019 Jun; 175(3):553-566. PubMed ID: 30852762
[TBL] [Abstract][Full Text] [Related]
35. PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development.
Tuncel H; Tanaka S; Oka S; Nakai S; Fukutomi R; Okamoto M; Ota T; Kaneko H; Tatsuka M; Shimamoto F
Int J Oncol; 2012 Dec; 41(6):2079-86. PubMed ID: 23042038
[TBL] [Abstract][Full Text] [Related]
36. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
[TBL] [Abstract][Full Text] [Related]
37. Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway.
Tian Y; Ye Y; Gao W; Chen H; Song T; Wang D; Mao X; Ren C
Int J Colorectal Dis; 2011 Jan; 26(1):13-22. PubMed ID: 20886344
[TBL] [Abstract][Full Text] [Related]
38. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
[TBL] [Abstract][Full Text] [Related]
39. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.
Alshaker H; Wang Q; Frampton AE; Krell J; Waxman J; Winkler M; Stebbing J; Cooper C; Yagüe E; Pchejetski D
Breast Cancer Res Treat; 2015 Jan; 149(1):59-67. PubMed ID: 25481644
[TBL] [Abstract][Full Text] [Related]
40. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
